S H Kelkar & Company Ltd Reports Sharp Decline in Profitability Despite Record Quarterly Sales

Quarterly Financial Performance: Revenue Growth Overshadowed by Profit Decline

The latest quarter saw S H Kelkar & Co. achieve its highest-ever net sales figure of ₹649.94 crores, reflecting robust top-line momentum in the specialty chemicals sector. This growth, however, failed to translate into earnings strength. The company’s PAT for the quarter stood at a mere ₹1.85 crores, marking a dramatic 91.5% decline relative to the average PAT over the preceding four quarters. Earnings per share (EPS) also hit a low of ₹0.13, underscoring the severe squeeze on shareholder returns.

Profit before tax excluding other income (PBT less OI) was at its lowest at ₹7.32 crores, indicating that core business operations are under significant strain. Notably, non-operating income accounted for nearly half (49.86%) of the total PBT, suggesting that the company’s profitability is increasingly reliant on non-core activities rather than operational efficiency.

Margin Pressure and Operational Challenges

Margins have contracted sharply, with return on capital employed (ROCE) dropping to a six-month low of 5.52%. This decline points to deteriorating capital efficiency and raises concerns about the company’s ability to generate adequate returns on its investments. The debt-equity ratio has climbed to its highest level in six months at 0.76 times, signalling increased leverage and potential financial risk.

Cash and cash equivalents have dwindled to ₹64.93 crores, the lowest in the half-year period, which may constrain liquidity and operational flexibility. Additionally, the debtors turnover ratio has fallen to 3.71 times, the lowest in six months, indicating slower collections and potential working capital challenges. Interest expenses surged to ₹15.03 crores, the highest quarterly figure recorded, further pressuring profitability.

Financial Trend Shift: From Negative to Very Negative

The company’s financial trend score has deteriorated sharply from -13 to -20 over the past three months, reflecting a transition from negative to very negative performance. This shift is driven primarily by the stark decline in profitability metrics despite the record sales. The widening gap between revenue growth and profit generation highlights operational inefficiencies and rising costs that the company has yet to control effectively.

Such a trend is concerning for investors, especially given the company’s small-cap status and the increasing financial leverage. The elevated debt levels combined with reduced cash reserves and higher interest costs could limit the company’s ability to invest in growth or weather economic headwinds.

Stock Performance and Market Comparison

S H Kelkar & Company Ltd’s stock price closed at ₹124.50, up marginally by 0.61% from the previous close of ₹123.75. The stock’s 52-week high and low stand at ₹275.20 and ₹111.70 respectively, indicating significant volatility and a steep downtrend over the past year.

When compared to the broader market benchmark, the Sensex, the company’s stock has underperformed markedly. Year-to-date (YTD), S H Kelkar’s stock has declined by 30.47%, while the Sensex has gained 12.67%. Over the past one year, the stock has fallen by 49.38%, contrasting with the Sensex’s modest 9.67% decline. Even over a five-year horizon, the stock has lost 20.60%, whereas the Sensex has surged 42.30%. This persistent underperformance reflects investor concerns about the company’s financial health and growth prospects.

Outlook and Analyst Ratings

Reflecting the deteriorating fundamentals, the company’s Mojo Score currently stands at 15.0, with a Mojo Grade of Strong Sell, an upgrade in severity from the previous Sell rating as of 15 May 2026. This downgrade underscores the heightened risk profile and the need for cautious investor approach.

Given the very negative financial trend, elevated debt levels, and shrinking profitability, analysts advise a conservative stance on S H Kelkar & Co. Investors should closely monitor upcoming quarterly results for signs of margin recovery or operational improvements before considering exposure.

Sector Context and Strategic Considerations

Operating within the specialty chemicals sector, which is often cyclical and capital intensive, S H Kelkar & Co.’s challenges are compounded by rising input costs and competitive pressures. The company’s inability to convert revenue growth into sustainable profit gains raises questions about cost management and pricing power.

Strategically, the firm may need to focus on deleveraging its balance sheet, improving working capital efficiency, and enhancing operational margins to regain investor confidence. Until such measures yield results, the stock is likely to remain under pressure relative to its sector peers and the broader market.

Conclusion

S H Kelkar & Company Ltd’s March 2026 quarter paints a complex picture of strong revenue growth overshadowed by a severe collapse in profitability and deteriorating financial health. The company’s elevated debt, declining cash reserves, and margin contraction present significant challenges that investors must weigh carefully. With a Strong Sell rating and a very negative financial trend, the stock currently appears unattractive compared to market benchmarks and sector alternatives.

Investors seeking exposure to the specialty chemicals space may find better risk-reward profiles elsewhere, pending a clear turnaround in S H Kelkar’s operational and financial metrics.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today